will tirzepatide go back on shortage list US judge sides with FDA's removal of Lilly's weight loss drug from Addressing the Weight Loss Injectable

Patients with cardiovascular concerns, glaucoma, or hyperthyroidism should avoid Qsymia due to its phentermine component

Designed to manage type 2 diabetes by regulating blood sugar, slowing digestion and reducing appetite, GLP-1s are now taken by millions of people across the world for weight loss, with Australian prescriptions increasing almost 10-fold since 2020 and use in the US more than quadrupling

This way, they can ensure youre taking the medication safely, and it will work effectively for you

Digestive Issues Women with Lipedema already have higher rates of: IBS Constipation Bloating SIBO (small intestinal bacterial overgrowth) Slow digestion GLP-1s slow gastric emptying even further, which can increase: Constipation Gastroparesis Reflux Nausea If digestive issues are present, they ideally should be addressed before starting GLP-1s